Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	5.05	37.75	35.93
Graham Fair Price	-16.14	17.92	21.36
PEG	40285.54	-1.00	< 0.005
Price/Book	-16.48	-8.34	-7.16
Price/Cash Flow	636.23	-169.13	22.97
Prices/Earnings	50.86	26.39	17.49
Price/Sales	15.35	0.50	0.43
Price/FCF	636.23	-169.13	22.97
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	6.71	0.03	0.03
Operating Margin	30.44	0.01	< 0.005
ROA	-25.81	< 0.005	< 0.005
ROE	-0.10	-0.08	22.79
ROIC	0.27	0.18	-35.49
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	0.24	< 0.005	2389.39
Dividends QOQ	-0.04	< 0.005	78.85
EBIT QOQ	35.43	0.25	-99.30
EPS QOQ	70.64	-0.26	-99.63
FCF QOQ	1.37	-1.15	-16.26
Revenue QOQ	0.05	-0.04	-9.93
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	29.87	29.32	-1.82
Days Sales Outstanding (DSO)	18.47	18.96	2.64
Inventory Turnover	3.01	3.07	1.86
Debt/Capitalization	3.71	2.26	-39.01
Quick Ratio	0.43	0.42	-1.60
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	-14.08	-13.44	4.56
Cash	18.74	15.30	-18.35
Capex	-0.47	-0.46	0.95
Free Cash Flow	4.39	-0.66	-84.90
Revenue	234.47	225.97	-3.62
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	0.98	0.98	0.07
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.19	2.75	1337.23
Naive Interpretation	Member

06 - Financial Health · Bad

Rating